Guardion Health Sciences to Report Second Quarter 2020 Financial Results on August 12, 2020
August 06 2020 - 4:05PM
Guardion Health Sciences, Inc. (Nasdaq: GHSI), a specialty health
sciences and nutrition therapy company, today announced it will
report financial results for its second quarter 2020 ended June 30,
2020 on Wednesday, August 12, 2020 following the close of the
market. The Company will host a conference call and webcast at 1:30
pm Pacific time (4:30 p.m. Eastern time) to discuss the results.
What: |
|
Guardion Health Sciences second quarter 2020 financial results
conference call. |
|
|
|
When: |
|
Wednesday, August 12, at 1:30 p.m. Pacific Time (4:30 p.m.
ET). |
|
|
|
Dial in Number: |
|
To access the live call, dial 800-353-6461 (US and Canada) or +1
334-323-0501 (International) and give the participant passcode
7353998. |
|
|
|
Webcast: |
|
To access the live webcast, please visit the investor relations
section at https://guardionhealth.com. |
|
|
|
Call Replay: |
|
A phone replay will be available approximately two hours following
the end of the call, and it will remain available for one week. To
access the call replay dial-in information, please click here. |
|
|
|
About Guardion Health Sciences, Inc.
Guardion is a specialty health sciences company
that (i) develops medical foods and medical devices for the ocular
health marketplace, and (ii) is developing nutraceuticals that the
Company believes will provide medicinal and health benefits to
consumers. Information and risk factors with respect to
Guardion and its business, including its ability to successfully
develop and commercialize its proprietary products and
technologies, may be obtained in the Company’s filings with the SEC
at www.sec.gov.
Forward-Looking Statement Disclaimer
With the exception of the historical information
contained in this news release, the matters described herein may
contain forward-looking statements within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E of
the Securities Exchange Act of 1934, as amended. Statements
preceded by, followed by or that otherwise include the words
“believes,” “expects,” “anticipates,” “intends,” “projects,”
“estimates,” “plans” and similar expressions or future or
conditional verbs such as “will,” “should,” “would,” “may” and
“could” are generally forward-looking in nature and not historical
facts, although not all forward-looking statements include the
foregoing. These statements involve unknown risks and
uncertainties that may individually or materially impact the
matters discussed herein for a variety of reasons that are outside
the control of the Company, including, but not limited to, the
Company’s ability to raise sufficient financing to implement its
business plan, the impact of the COVID-19 pandemic on the Company’s
business, operations and the economy in general, and the Company’s
ability to successfully develop and commercialize its proprietary
products and technologies. Readers are cautioned not to place
undue reliance on these forward- looking statements, as actual
results could differ materially from those described in the
forward-looking statements contained herein. Readers are
urged to read the risk factors set forth in the Company’s filings
with the SEC, which are available at the SEC’s website
(www.sec.gov). The Company disclaims any intention or
obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or
otherwise.
Investor Relations Contact:
Todd Kehrli or Jim ByersMKR Investor Relations,
Inc.ghsi@mkr-group.com
Guardion Health Sciences (NASDAQ:GHSI)
Historical Stock Chart
From Apr 2024 to May 2024
Guardion Health Sciences (NASDAQ:GHSI)
Historical Stock Chart
From May 2023 to May 2024